RGEN vs BAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

RGEN

48.7
AI Score
VS
RGEN Wins

BAX

41.7
AI Score

Investment Advisor Scores

RGEN

49score
Recommendation
HOLD

BAX

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RGEN BAX Winner
Forward P/E 67.1141 11.5741 BAX
PEG Ratio 1.8399 36.6767 RGEN
Revenue Growth 11.9% 5.3% RGEN
Earnings Growth -65.9% 36.8% BAX
Tradestie Score 48.7/100 41.7/100 RGEN
Profit Margin 5.3% -9.3% RGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

RGEN 1M: -3.2% · 3M: +35.4% BAX 1M: +9.2% · 3M: +14.5%

Current Technical Phase

RGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.7% over 20 days), RSI 51

RSI (14): 51.0 · Price: $178.71

BAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.9 · Price: $25.65

Fundamentals Snapshot

Metric RGEN BAX
Market Cap — —
Forward P/E 66.3 12.6
Trailing P/E 246.6 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.73 -1.88
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.